Skip to content
Vancomycin
Firvanq, Vancocin (vancomycin) is a small molecule pharmaceutical. Vancomycin was first approved as Vancocin hydrochloride on 1982-01-01. It is used to treat bacterial endocarditis, bacterial infections, diarrhea, neutropenia, and pneumococcal meningitis amongst others in the USA.
Download report
Favorite
Searched
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
nervous system diseasesD009422
cardiovascular diseasesD002318
hemic and lymphatic diseasesD006425
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Firvanq, Vancocin (generic drugs available since 1983-07-13, discontinued: Vancoled, Vancor)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Vancomycin
Tradename
Company
Number
Date
Products
VANCOMYCINXelliaN-213895 RX2021-08-26
1 products, RLD, RS
Vancomycin hydrochloride
Tradename
Company
Number
Date
Products
VANCOCIN HYDROCHLORIDEANI PHARMSN-050606 RX1986-04-15
2 products, RLD, RS
FIRVANQ KITAzurityN-208910 RX2018-01-26
2 products, RLD, RS
VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINERBaxterN-050671 RX1993-04-29
3 products, RLD, RS
VANCOMYCIN HYDROCHLORIDEMylanN-209481 RX2018-07-10
3 products, RLD, RS
VANCOMYCIN HYDROCHLORIDEXelliaN-211962 RX2019-02-15
7 products, RLD, RS
VANCOMYCIN HYDROCHLORIDEZhejiang Novus PharmaceuticalsN-210274 RX2023-01-20
4 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
firvanqNew Drug Application2021-12-17
vancocinNew Drug Application2022-01-04
vancomycin hydrochlorideANDA2023-05-19
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial endocarditisEFO_1000830D004697—
bacterial infections—D001424A49
diarrheaHP_0002014D003967R19.7
neutropenia—D009503D70
pneumococcal meningitisEFO_1001114D008586G00.1
postoperative complications—D011183—
pseudomembranous enterocolitisEFO_1001314D004761A04.7
staphylococcal infections—D013203A49.01
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Vancomycin, Vancomycin, Xellia Pharms Aps
100398042035-11-06DPU-282
101886972035-11-06DPU-282
108499562035-11-06DP
110005672035-11-06DP
115176092035-11-06U-282
Vancomycin Hydrochloride, Vancomycin Hydrochloride, Xellia Pharms Aps
116282002035-11-06DP
Vancomycin Hydrochloride, Firvanq Kit, Azurity
104930282035-03-13DP
106880462035-03-13DP
109599462035-03-13DP
109599472035-03-13DPU-3104, U-3105
109599482035-03-13DPU-3104, U-3105
109599492035-03-13DPU-3104, U-3105
116386922035-03-13DP
ATC Codes
A: Alimentary tract and metabolism drugs
— A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents
— A07A: Intestinal antiinfectives
— A07AA: Antibiotics, intestinal
— A07AA09: Vancomycin
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01X: Other antibacterials in atc
— J01XA: Glycopeptide antibacterials
— J01XA01: Vancomycin
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AA: Antibiotics, ophthalmologic
— S01AA28: Vancomycin
HCPCS
Code
Description
J3370
Injection, vancomycin hcl, 500 mg
Clinical
Clinical Trials
356 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Clostridium infectionsD003015EFO_1000874A05.24111910444
InfectionsD007239EFO_000054424781130
Surgical wound infectionD0135301359622
BacteremiaD016470EFO_0003033R78.81—547217
Methicillin-resistant staphylococcus aureusD0556242125212
Clostridioides difficileD016360NCBITaxon_1496—444112
SepsisD018805A41.91—22611
Soft tissue infectionsD018461—16119
EndocarditisD004696EFO_0000465I33—12429
Wound infectionD014946—243—9
Show 41 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Bacterial infectionsD001424A49155—112
Cystic fibrosisD003550EFO_0000390E84221——5
AbscessD000038EFO_0003030—14——5
NeoplasmsD009369C80121—14
InflammationD0072491—2——3
Bacterial pneumoniaD018410EFO_1001272J15.9—12——3
Skin diseasesD012871L00-L99——2——2
NeutropeniaD009503D70——1—12
Bacterial skin diseasesD017192——2——2
Cross infectionD003428——1——1
Show 20 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ulcerative colitisD003093EFO_0000729K5122——15
Autism spectrum disorderD000067877F84.023——15
ObesityD009765EFO_0001073E66.911——24
Colorectal neoplasmsD01517913———3
Respiratory tract infectionsD012141J06.911——13
Healthcare-associated pneumoniaD000077299—1——23
MelanomaD00854521———2
Liver neoplasmsD008113EFO_1001513C22.0—2———2
Neonatal sepsisD000071074HP_0040187—1——12
Crohn diseaseD003424EFO_0000384K50—2———2
Show 17 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Critical illnessD0166381———34
Inflammatory bowel diseasesD015212EFO_00037671———23
Healthy volunteers/patients—2———13
Biliary atresiaD001656EFO_0004217Q44.22————2
OsteoporosisD010024EFO_0003882M81.01————1
Hand injuriesD0062301————1
OsteoarthritisD010003EFO_0002506M15-M191————1
Respiratory insufficiencyD012131HP_0002093J96.91————1
Non-small-cell lung carcinomaD0022891————1
DialysisD0039561————1
Show 2 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Acute kidney injuryD058186HP_0001919N17————22
ColitisD003092EFO_0003872K52.9————22
Bacterial meningitisD016920EFO_1000831G00————11
Acinetobacter infectionsD000151EFO_1000792————11
Cerebral hemorrhageD002543————11
Subarachnoid hemorrhageD013345EFO_0000713I60————11
Drug monitoringD016903————11
MediastinitisD008480J98.51————11
Psoriatic arthritisD015535EFO_0003778L40.5————11
Rheumatoid arthritisD001172EFO_0000685M06.9————11
Show 24 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameVANCOMYCIN
INNvancomycin
Description
Vancomycin is a complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile. It has a role as an antimicrobial agent, an antibacterial drug and a bacterial metabolite. It is functionally related to a vancomycin aglycone. It is a conjugate base of a vancomycin(1+).
Classification
Small molecule
Drug classantibiotics (Streptomyces strain)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O
Identifiers
PDB—
CAS-ID1404-90-6
RxCUI11124
ChEMBL IDCHEMBL262777
ChEBI ID28001
PubChem CID14969
DrugBankDB00512
UNII ID6Q205EH1VU (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 91,478 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
65,910 adverse events reported
View more details